Related Experiment Video
Updated: Aug 19, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Skin carcinoma arising from donor cells in a kidney transplant recipient
Sélim Aractingi1, Jean Kanitakis, Sylvie Euvrard
1Unité de Dermatologie, Hôpital Tenon, Paris, France.
Abstract:
The incidence of skin cancer is increased in transplant recipients. UV radiation, papillomaviruses, and immunosuppression participate in the pathogenesis of these tumors. In addition, donor cells may leave the grafted organ, reach peripheral tissues and either induce immune phenomena or possibly take part in tissue remodeling. Herein, we investigated the possible involvement of donor cells in the development of skin tumors in kidney allograft recipients. We analyzed a series of 48 malignant and benign cutaneous tumors developing in 14 females who had been grafted with a male kidney. The number of male cells was measured on microdissected material by quantitative PCR for Y chromosome. In the samples with high levels of male cells, fluorescent in situ hybridization (FISH) with X and Y probes and/or immuno-FISH with anticytokeratin antibodies were carried out. Male cells were detected in 5/15 squamous cell carcinomas and Bowen disease (range 4-180 copies), 3/5 basal cell carcinomas (91-645), 6/11 actinic keratosis (7-102), 2/4 keratoacanthoma (22-41), and 2/5 benign cutaneous lesions (14-55). In a basal cell carcinoma specimen with a high number of male cells, FISH showed that most cells within the tumoral buds were XY. In this lesion, immuno-FISH showed the presence of XY cytokeratin-positive cells indicating that the tumor nests contained male keratinocytes. In contrast, in other female transplants, male cells present in the tumors were not epithelial. In conclusion, stem cells originating from a grafted kidney may migrate to the skin, differentiate, or fuse as keratinocytes that could, rarely, undergo cancer transformation.
Insights
Donor stem cells from kidney transplants may migrate to the skin, differentiate into keratinocytes, and rarely contribute to skin cancer development in transplant recipients.
Area of Science:
- Transplantation immunology
- Dermatology
- Oncology
Background:
- Kidney transplant recipients have an increased risk of skin cancer.
- Donor cells can disseminate from transplanted organs to peripheral tissues.
- The role of donor cells in post-transplant skin tumorigenesis is unclear.
Purpose of the Study:
- To investigate the presence and role of donor cells in skin tumors of kidney allograft recipients.
- To determine if donor keratinocytes contribute to skin cancer development.
Main Methods:
- Analysis of 48 cutaneous tumors from 14 female kidney allograft recipients (male donors).
- Quantitative PCR for Y chromosome to detect male cells.
- Fluorescent in situ hybridization (FISH) and immuno-FISH to identify cell type and origin.
Main Results:
- Male cells were detected in various skin tumors, including squamous cell carcinoma, basal cell carcinoma, actinic keratosis, and keratoacanthoma.
- In one basal cell carcinoma, FISH confirmed XY cells within tumoral nests.
- Immuno-FISH identified male keratinocytes in this tumor, suggesting donor-derived epithelial contribution.
Conclusions:
- Donor stem cells from kidney grafts can migrate to the skin.
- These cells may differentiate into keratinocytes and, rarely, undergo malignant transformation.
- This finding offers a novel insight into skin cancer development in transplant patients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Kidney Transplant III: Nursing Management
